[{"Assets_0_FY_USD":1422286000.0,"CommonStockSharesOutstanding_0_FY_shares":299876080.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":415720000.0,"NetIncomeLoss_4_FY_USD":690070000.0,"NetIncomeLoss_1_FY_USD":360089000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":297892000.0,"EarningsPerShareBasic_4_FY_USD":2.32,"EarningsPerShareBasic_1_FY_USD":1.2,"Ticker":"EXEL","CIK":"939767","name":"EXELIXIS, INC.","OfficialName":"Exelixis Inc. Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7287350058.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20190222"}]